Szinai I, Veres Z, Ganzler K, Hegedus-Vajda J, De Clercq E
Central Research Institute for Chemistry, Hungarian Academy of Sciences, Budapest.
Eur J Drug Metab Pharmacokinet. 1991 Apr-Jun;16(2):129-36. doi: 10.1007/BF03189949.
The enzymatic splitting and metabolic elimination of anti-viral agent 5-(2-chloroethyl)-2'-deoxyuridine [CEDU] have been studied. For elucidation of structures of metabolites, several different kinds of extraction, purification and spectroscopic methods were used (Extrelut LC, TLC, HPLC, MS, NMR, IR, UV and CD). For mass spectral analysis, various ionization techniques (EI, CI and FAB-MS) were performed as complementary methods. After oral administration of [14C]-CEDU to mice and rats, the parent compound, 5-(2chloroethyl) uracil [CEU] and hydroxylated CEU metabolites were isolated and identified from urine and faeces by the above mentioned methods. The CEDU showed rapid phosphorolysis in vitro with thymidine phosphorylase Km 41.0 +/- 5.0; and uridine phosphorylase Km 10.0 +/- 1.5. The cleavage of the N-glycosidic bond of the nucleoside analogue and a new metabolic pathway of CEDU [stereoselective oxidation of 5-(2-chloroethyl) uracil] was observed in both species.
已对抗病毒药物5-(2-氯乙基)-2'-脱氧尿苷[CEDU]的酶促裂解和代谢消除进行了研究。为阐明代谢产物的结构,使用了几种不同的提取、纯化和光谱方法(Extrelut LC、TLC、HPLC、MS、NMR、IR、UV和CD)。对于质谱分析,采用了各种电离技术(EI、CI和FAB-MS)作为补充方法。给小鼠和大鼠口服[14C]-CEDU后,通过上述方法从尿液和粪便中分离并鉴定出母体化合物、5-(2-氯乙基)尿嘧啶[CEU]和羟基化的CEU代谢产物。CEDU在体外与胸苷磷酸化酶(Km 41.0±5.0)和尿苷磷酸化酶(Km 10.0±1.5)发生快速磷酸解。在这两个物种中均观察到核苷类似物的N-糖苷键裂解以及CEDU的一条新代谢途径[5-(2-氯乙基)尿嘧啶的立体选择性氧化]。